BRPI0922219A2 - processo para a produção de vacinas - Google Patents

processo para a produção de vacinas

Info

Publication number
BRPI0922219A2
BRPI0922219A2 BRPI0922219A BRPI0922219A BRPI0922219A2 BR PI0922219 A2 BRPI0922219 A2 BR PI0922219A2 BR PI0922219 A BRPI0922219 A BR PI0922219A BR PI0922219 A BRPI0922219 A BR PI0922219A BR PI0922219 A2 BRPI0922219 A2 BR PI0922219A2
Authority
BR
Brazil
Prior art keywords
vaccine production
vaccine
production
Prior art date
Application number
BRPI0922219A
Other languages
English (en)
Inventor
Reineke Jessica
Original Assignee
Boehringer Ingelheim Vetmedica Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42022135&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0922219(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Vetmedica Gmbh filed Critical Boehringer Ingelheim Vetmedica Gmbh
Publication of BRPI0922219A2 publication Critical patent/BRPI0922219A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BRPI0922219A 2008-12-03 2009-12-01 processo para a produção de vacinas BRPI0922219A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08170591 2008-12-03
PCT/EP2009/066109 WO2010063693A1 (en) 2008-12-03 2009-12-01 Process for production of vaccines

Publications (1)

Publication Number Publication Date
BRPI0922219A2 true BRPI0922219A2 (pt) 2018-10-23

Family

ID=42022135

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0922219A BRPI0922219A2 (pt) 2008-12-03 2009-12-01 processo para a produção de vacinas

Country Status (18)

Country Link
US (1) US20110243991A1 (pt)
EP (1) EP2373332A1 (pt)
JP (1) JP2012510497A (pt)
KR (1) KR20110100189A (pt)
CN (1) CN102238960B (pt)
AR (1) AR074455A1 (pt)
AU (1) AU2009324180A1 (pt)
BR (1) BRPI0922219A2 (pt)
CA (1) CA2737403A1 (pt)
CL (1) CL2011001284A1 (pt)
CO (1) CO6390040A2 (pt)
MX (1) MX2011005758A (pt)
RU (1) RU2011126602A (pt)
SG (1) SG171934A1 (pt)
TW (1) TW201026852A (pt)
UA (1) UA105508C2 (pt)
WO (1) WO2010063693A1 (pt)
ZA (1) ZA201101645B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2507553T3 (es) * 2006-08-02 2014-10-15 Johannes Gutenberg-Universität Mainz Fármaco contra intoxicaciones por LCT
AU2008299885C1 (en) 2007-09-14 2015-06-25 Sanofi Pasteur Biologics, Llc Pharmaceutical compositions containing clostridium difficile toxoids A and B
CN103619871B (zh) 2011-04-22 2016-12-14 惠氏有限责任公司 涉及突变体难辨梭菌毒素的组合物及其方法
BR122016023101B1 (pt) 2012-10-21 2022-03-22 Pfizer Inc Polipeptídeo, composição imunogênica que o compreende, bem como célula recombinante derivada de clostridium difficile
US8909605B1 (en) * 2013-02-28 2014-12-09 Emc Corporation Method and system for accelerating data movement using change information concerning difference between current and previous data movements
WO2014176276A1 (en) * 2013-04-22 2014-10-30 Board Of Regents Of The University Of Oklahoma Clostridium difficile vaccine and methods of use
CN109865135A (zh) * 2019-03-18 2019-06-11 宁波大学 一种银鲳美人鱼发光杆菌和灿烂弧菌联合灭活疫苗
KR102376876B1 (ko) * 2020-04-09 2022-03-21 대진대학교 산학협력단 무독성의 클로스트리디움 디피실 독소단백질-단편 및 이의 용도
WO2021255690A2 (en) 2020-06-19 2021-12-23 Pfizer Inc. Immunogenic compositions against clostridioides (clostridium) difficile and methods thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6967088B1 (en) * 1995-03-16 2005-11-22 Allergan, Inc. Soluble recombinant botulinum toxin proteins
NZ312876A (en) * 1995-07-07 2000-06-23 Oravax Inc Intranasal, muscosal and systemic vaccination against C. difficile inducing a mucosal immune response in the gastrointestinal and/or genitourinary tracts
JP2002542169A (ja) * 1999-04-09 2002-12-10 テクラブ， インコーポレイテッド Ｃｌｏｓｔｒｉｄｉｕｍｄｉｆｆｉｃｉｌｅに対する、組換え毒素Ａ／毒素Ｂワクチン
US7226597B2 (en) * 2002-06-17 2007-06-05 The Board Of Regents Of The University Of Oklahoma Mutants of Clostridium difficile toxin B and methods of use
WO2007146139A2 (en) * 2006-06-08 2007-12-21 Cornell Research Foundation, Inc. Codon-optimized dna molecules encoding the receptor binding domains of clostridium difficile toxins a and b
ES2507553T3 (es) * 2006-08-02 2014-10-15 Johannes Gutenberg-Universität Mainz Fármaco contra intoxicaciones por LCT

Also Published As

Publication number Publication date
KR20110100189A (ko) 2011-09-09
CL2011001284A1 (es) 2011-09-16
CA2737403A1 (en) 2010-06-10
UA105508C2 (uk) 2014-05-26
CN102238960A (zh) 2011-11-09
AU2009324180A1 (en) 2010-06-10
WO2010063693A1 (en) 2010-06-10
MX2011005758A (es) 2011-06-28
ZA201101645B (en) 2011-11-30
CN102238960B (zh) 2014-04-23
CO6390040A2 (es) 2012-02-29
JP2012510497A (ja) 2012-05-10
RU2011126602A (ru) 2013-01-10
US20110243991A1 (en) 2011-10-06
SG171934A1 (en) 2011-07-28
TW201026852A (en) 2010-07-16
EP2373332A1 (en) 2011-10-12
AR074455A1 (es) 2011-01-19

Similar Documents

Publication Publication Date Title
BRPI0915017A2 (pt) Processo para a produção de álcool
BRPI0910916A2 (pt) Processo para a produção de um dianidroaçúcar
BRPI0910910A2 (pt) processo para preparar um composto
BRPI0910911A2 (pt) processo para preparar um composto
BRPI0812304A2 (pt) Processo para a produção de p4o6
BRPI0918349A2 (pt) Processo para preparar dióxido de divinilareno
BRPI0923180A2 (pt) processo para a produção de produtos químicos
BRPI1012018A2 (pt) processo para preparar um composto
BRPI0811644A2 (pt) Processo para a produção de pirazóis
BRPI1014267A2 (pt) processo para a carbonitrificação
BRPI1013561A2 (pt) Processo para a preparação de alogliptina
BRPI1014812A2 (pt) Processo para a produção de alacoóis
BRPI0913217A2 (pt) processo para a produção de etileno
BRPI0917984A2 (pt) processo em batelada para a produção de poliamidas
BRPI0915572A2 (pt) processo para a fabricação de epicloroidrina
BRPI0810067A2 (pt) Processo para a preparação de capecitabina
BR112012014490A2 (pt) processo para a preparação substituída de 1-o-acil-2-desóxi-2-fluoro-4-tio-beta-d-arabinofuranoses
BRPI0914788A2 (pt) Processo para a produção de um produto intermediário de etexilato de dabigatran
BRPI0910265A2 (pt) processo para a produção de quitosana.
BRPI0909004A2 (pt) Processo para produção de biogás
BRPI0813960A2 (pt) Processo para produção de biarilas
BRPI0912558A2 (pt) Processo para a preparação de amidas
BRPI0922219A2 (pt) processo para a produção de vacinas
BRPI0908900A2 (pt) processo para a produção de polióis
BRPI0921420A2 (pt) processo para preparar compostos

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 6A, 7A, 8A E 9A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2495 DE 30-10-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.